QR Code

Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices

This study assessed the total costs of testing, including the estimated costs of delaying care, associated with next-generation sequencing (NGS) versus single-gene testing strategies among patients with newly diagnosed metastatic non-small cell lung cancer (mNSCLC) from a Canadian public payer persp...

Description complète

Enregistré dans:
Auteurs principaux: Brandon S. Sheffield, Kiefer Eaton, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison, Andrea L. Stevens, Emmanuel M. Ewara, Parneet Cheema
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2023-02-01
Collection:Current Oncology
Sujets:
non-small cell lung cancer
economic model
next-generation sequencing
testing costs
medical costs
Accès en ligne:https://www.mdpi.com/1718-7729/30/2/180
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires